跳至主要内容
临床试验/NCT02747147
NCT02747147已完成不适用

Multi-Day Evaluation of the TIVA Device

Velano Vascular, Inc.2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2016年4月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
160
试验地点
2
主要终点
% of Specimen hemolyzed

研究概览

简要总结

Prospective, randomized, single-center study to evaluate the ability of the device to collect good quality blood samples from patients with peripheral IV access over the length of their stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient will be admitted to the BWH unit 15 for post-surgical care
  • Patient is at least 18 years old
  • Patient is willing and physically / cognitively able to sign a written consent form
  • Patient is willing and able to complete study questionnaires
  • Patient is NOT a prisoner

排除标准

  • Active hemodialysis
  • Hemolytic disorders (e.g., sickle cell disease)
  • Pregnancy

结局指标

主要结局

% of Specimen hemolyzed

时间窗: up to 4 days

each collected specimen will be analyzed for hemolysis. The hemolysis rate, or % of specimen that are hemolyzed will be reported over all collections.

% Aspiration reliability

时间窗: up to 4 days after PIV placement

blood aspiration with the device is attempted once per day. The % of attempts that are successful will be reported across all attempts

次要结局

  • Avg PIV dwell - hours, mean, range(1, 2, 3, and 4 calendar days after PIV placement)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验